首页 › 基金 › Venrock Adviser, LLC › SRZN

Venrock Adviser, LLC 对 SRZN 的持仓历史

SURROZEN INC · 医疗保健

Venrock Adviser, LLC 在 Q3 2026 的 13F 申报中披露持有 SRZN(SURROZEN INC)632,931 股,市值约 US$20.4M,约占其申报组合的 0.99%,在其申报持仓中市值排名第 24 位。 Venrock Adviser, LLC 最近 7 个申报季度中有 7 个季度披露了 SRZN 持仓,最早可追溯至 Q1 2025。

最新持仓 (Q3 2026)632.93K 股
申报持仓市值$20.37M
组合权重0.99%
首次申报Q1 2025
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Venrock Adviser, LLC 对 SRZN 的持仓演变

Venrock Adviser, LLC 于 Q1 2025 首次披露 SRZN 持仓:632,931 股(约 US$7.4M)。 该持仓在 Q3 2026 达到峰值 632,931 股,市值约 US$20.4M。 在 7 次申报中,Venrock Adviser, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 632,931 股、市值约 US$20.4M。

逐季持仓明细

季度股数金额变化
Q1 2025 632.93K $7.38M 新进
Q2 2025 632.93K $5.66M 持有
Q3 2025 632.93K $8.16M 持有
Q4 2025 632.93K $14.30M 持有
Q1 2026 632.93K $18.44M 持有
Q2 2026 632.93K $16.42M 持有
Q3 2026 632.93K $20.37M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SRZN 与 13F 数据

SRZN(SURROZEN INC)属于医疗保健行业。我们追踪的基金中还有 59 只申报持有 SRZN,申报仓位最大的包括:Column Group LLC (US$76.6M), Boxer Capital Management, LLC (US$43.8M), Commodore Capital LP (US$28.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SRZN 的基金

查看 SRZN 的全部基金持有人 →

常见问题

How long has Venrock Adviser, LLC held SRZN?

Venrock Adviser, LLC has disclosed SRZN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Venrock Adviser, LLC's current position in SRZN?

As of Q3 2026, Venrock Adviser, LLC holds 632.93K shares of SRZN (SURROZEN INC), valued at $20.37M, representing 0.99% of its reported portfolio and ranking #24.

Has Venrock Adviser, LLC been buying or selling SRZN?

In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in SRZN. The position peaked in Q3 2026 at 632.93K shares.

Which other funds hold SRZN?

Other major institutional holders of SRZN include Column Group LLC, Boxer Capital Management, LLC, Commodore Capital LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.